Consensus Organ at Risk Constraints for Radiation Therapy of Hematologic Malignancies for NCTN Trials
Google Scholar   
Citation:
Meeting Instance:
ASTRO 2025
Year:
2025
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
4838  
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA180868, U10 CA180821, U10 CA180820, U10 CA180899, U10CA180888, U10 CA180886, U10CA180863, CCS 707213  
Corr. Author:
 
Authors:
                               
Networks:
CA016, FL085, KANSAS, LAPS-CO070, LAPS-MN026, LAPS-NC010, LAPS-OH007, MN022   
Study
No Study Assigned
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
N/A
Keywords: